about
Mechanism of differential activities of ofloxacin enantiomersIn vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosisIn vitro activities of levofloxacin used alone and in combination with first- and second-line antituberculous drugs against Mycobacterium tuberculosisSpectrum of activity of levofloxacin against nontuberculous mycobacteria and its activity against the Mycobacterium avium complex in combination with ethambutol, rifampin, roxithromycin, amikacin, and clofazimineLevofloxacin in vitro activity: results from an international comparative study with ofloxacin and ciprofloxacin.Inhibition by quinolones of DNA gyrase from Staphylococcus aureus.Prevalence of resistance to three fluoroquinolones: assessment of levofloxacin disk test error rates and surrogate predictors of levofloxacin susceptibility. AST Surveillance Group.Association between early inhibition of DNA synthesis and the MICs and MBCs of carboxyquinolone antimicrobial agents for wild-type and mutant [gyrA nfxB(ompF) acrA] Escherichia coli K-12Antagonism of wild-type and resistant Escherichia coli and its DNA gyrase by the tricyclic 4-quinolone analogs ofloxacin and S-25930 stereoisomers.Effect of DNA gyrase inhibitors pefloxacin, five other quinolones, novobiocin, and clorobiocin on Escherichia coli topoisomerase I.In vitro activity of DR-3355, an optically active ofloxacinIn vitro activity of S-ofloxacin.Novel 1-8-bridged chiral quinolones with activity against topoisomerase II: stereospecificity of the eukaryotic enzyme.Pharmacodynamics of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with rifampin, against methicillin-susceptible and -resistant Staphylococcus aureus in an in vitro infection modelAntimicrobial activity of DV-7751a, a new fluoroquinoloneSusceptibility to levofloxacin predicted from in vitro susceptibility testing results obtained with ciprofloxacin and with ofloxacin.In vitro and in vivo antibacterial activities of E-4497, a new 3-amine-3-methyl-azetidinyl tricyclic fluoroquinolone.Levofloxacin inhalation solution for the treatment of chronic Pseudomonas aeruginosa infection among patients with cystic fibrosis.Clinical pharmacokinetics of inhaled antimicrobials.Uptake and intracellular activity of an optically active ofloxacin isomer in human neutrophils and tissue culture cells.Mechanisms of clinical resistance to fluoroquinolones in Enterococcus faecalis.Selective biotransformations. Patents and literature.
P2860
Q24675769-D41808D9-28BE-4F7F-89A2-9BDC1C35683FQ28367763-A9EF96BF-19A7-4CC8-A57B-5ABBD0F18526Q28379137-8817BB48-73BF-47FC-ADC7-4D3711DC60D0Q28379290-BC69EA4F-81AD-47BD-AA01-83FE262099AFQ34333286-695742FA-54DF-4BFE-8A4B-09B1EC3977C2Q34566027-E7C7A2C9-1D9B-4078-A548-C97C409256F9Q35125533-4ACB2CC3-FE08-45DB-8D8B-F83C3F3C6914Q35315975-84069CC1-F189-4BDF-874F-981526290E16Q35543768-2A608BBD-A7EA-4596-9A97-351BA5236C8FQ35562756-AFFD1660-8612-4BBD-8634-5F86AFA2B54BQ35563775-8620744F-1A07-400F-A116-847EAFD7AB38Q35566524-96893E0A-CB67-441C-BCF2-D9212EF796FDQ35810950-40D42F65-93A2-402A-8F2C-022BC89D6AE5Q35822889-4ACA07F4-6066-4013-8F54-729DAEB6CC7AQ35897320-36FABE6E-6EE3-4700-A159-D2EDB2CB0BBBQ36517614-B9773103-C0C6-46A4-962A-58FEC4300755Q36753046-276C8D55-1F3E-4F44-ABA6-02D457FA4BA8Q38270626-F360C83B-BD8F-4A82-BF02-72F04929917AQ38367260-9CF037C5-EC67-4DF3-A638-AF3CEEA9732CQ39815370-1B8C9BDF-701A-4085-A6FF-1BC597BA98B9Q40284197-868DD979-76BB-483B-A54D-5F04F6C82C7CQ44628904-09980D8B-6D9D-41F0-9B34-87AB9ED35D1A
P2860
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
Inhibition of DNA gyrase by optically active ofloxacin
@en
Inhibition of DNA gyrase by optically active ofloxacin.
@nl
type
label
Inhibition of DNA gyrase by optically active ofloxacin
@en
Inhibition of DNA gyrase by optically active ofloxacin.
@nl
prefLabel
Inhibition of DNA gyrase by optically active ofloxacin
@en
Inhibition of DNA gyrase by optically active ofloxacin.
@nl
P2093
P2860
P356
P1476
Inhibition of DNA gyrase by optically active ofloxacin
@en
P2093
P2860
P304
P356
10.1128/AAC.31.2.325
P407
P577
1987-02-01T00:00:00Z